Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVolex Regulatory News (VLX)

Share Price Information for Volex (VLX)

Share Price is delayed by 15 minutes
Get Live Data
679.00    0.00 (0.00%)
Bid:
669.00
Ask:
544.00
Spread: -125.00 (-18.685%)
Market Cap: £1.25b
VLX Live PriceLast checked at - London Stock Exchange

Intraday Volex Share Chart

Holding(s) in Company

8 Jun 2007 09:39

Volex Group PLC08 June 2007 TR-l: NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Identity of the issuer or the underlying issuer of existingshares to which voting rights are attached (ii): VOLEX GROUP PLC 2. Reason for the notification: (please state Yes/No): An acquisition or disposal of voting rights: yes An acquisition or disposal of financial instruments, which may result in theacquisition of shares already issued to which voting rights are attached: An event changing the breakdown of voting rights: Other (please specify) 3. Full name of the person(s) subject to the notificationobligation: THE GOLDMAN SACHS GROUP, INC. 4. Full name of shareholder(s) (if different from 3.): GOLDMAN SACHS & CO.GOLDMAN SACHS INTERNATIONALGOLDMAN SACHS ASSET MANAGEMENT INTERNATIONAL &GOLDMAN SACHS ASSET MANAGEMENT, L.P. 5. Date of the transaction and date on which the threshold iscrossed or reached: 10 MAY 2007 6. Date on which issuer notified: 7 JUNE 2007 7. Threshold(s) that is/are crossed or reached: 17% 8. Notified details: A: Voting rights attached to shares Class /type of Situation Previous to Resulting situation after the Triggering Transactionshares the Triggering Transaction If possible using Number of Number of Number Number of voting % of voting Rightsthe voting Shares of RightsixISIN CODE Rightsviii shares Directx Directxi Indirect Direct Indirect GB0009390070 9,250,347 16.33% 4,222,263 5,501,346 7.46% 9.71% B: Financial Instruments Resulting situation after the triggering transactionxii Type of Expiration Date xiii Exercise Number of voting % of votingfinancial Conversion Period Rights that may be rightsinstrument / Date xiv Acquired if the instrument is exercised/converted. - - - - - Total (A+B) Number of voting rights % of voting rights 9,723,609 17.15% 9. Chain of controlled undertakings through which the votingrights and/or the financial instruments are effectively held, if applicable xv The interest in 5,467,548 shares arose from an interest held by Goldman, Sachs &Co., a wholly-owned direct subsidiary of GS Inc, acting as custodian for itscustomers. These shares are, or will be, registered in the name of Goldman SachsSecurities (Nominees), Limited. The interest in 4,222,263 shares arose from a beneficial interest held byGoldman Sachs International, a wholly-owned indirect subsidiary of GS Inc. Theseshares are, or will be, registered at CREST in account CREPTEMP. The interest in 29,741 shares arose from the interest held by Goldman SachsAsset Management International, a wholly owned subsidiary of GS Inc acting asdiscretionary manager. We believe that some of these shares are, or will be,registered in the name of GSSN. The interest in 4,057 shares arose from the interest held by Goldman Sachs AssetManagement, LP a wholly owned subsidiary of GS Inc acting as discretionarymanager. We believe that some of these shares are, or will be, registered inthe name of GSSN. Proxy Voting: 10. Name of the proxy holder: not applicable 11. Number of voting rights proxy holder will cease to hold: not applicAble 12. Date on which proxy holder will cease to hold voting rights: not applicAble 13. Additional information not applicAble 14. Contact name: wendy tate company secretary 15. Contact telephone number: 01925 830101 END 8 June 2007 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
26th May 20263:00 pmRNSNotice of Results
15th May 20267:45 amRNSHolding(s) in Company
11th May 20267:00 amRNSHolding(s) in Company
30th Apr 20263:07 pmRNSHolding(s) in Company
22nd Apr 20267:00 amRNSCapital Markets Event
7th Apr 20267:00 amRNSLaunch of £40 million Share Buyback Programme
7th Apr 20267:00 amRNSUpdate on Move to the Main Market
26th Mar 20265:30 pmRNSHolding(s) in Company
25th Mar 20267:00 amRNSTrading update and Notice of Capital Markets Event
20th Mar 20262:00 pmRNSDirector/PDMR Shareholding
10th Feb 20267:45 amRNSHolding(s) in Company
2nd Feb 20264:45 pmRNSDirector/PDMR Shareholding
30th Jan 20264:30 pmRNSDirector/PDMR Shareholding
21st Jan 20267:00 amRNSTrading Update
12th Jan 20265:30 pmRNSDirector/PDMR Shareholding
8th Jan 20262:00 pmRNSDirector/PDMR Shareholding
5th Jan 20263:00 pmRNSIssue of Equity and Total Voting Rights
15th Dec 20257:00 amRNSDirector/PDMR Shareholding
11th Dec 20255:55 pmRNSDirector/PDMR Shareholding
4th Dec 202511:30 amRNSScrip Reference Price
12th Nov 20257:00 amRNSAppointment of Non-Executive Chair and CEO
12th Nov 20257:00 amRNSHalf-year Report
20th Oct 20257:00 amRNSNotice of Results
16th Oct 20257:00 amRNSHalf Year Trading Update
29th Sep 20251:25 pmRNSHolding(s) in Company
18th Sep 20257:00 amRNSHolding(s) in Company
15th Sep 202511:30 amRNSDirector/PDMR Shareholding
15th Sep 202510:15 amRNSHolding(s) in Company
5th Sep 20259:00 amRNSDirector/PDMR Shareholding
1st Sep 20251:00 pmRNSIssue of Equity and Total Voting Rights
7th Aug 20254:35 pmRNSResult of AGM
7th Aug 202512:30 pmRNSScrip Reference Price
7th Aug 20257:00 amRNSAGM Statement
4th Aug 20252:00 pmRNSHolding(s) in Company
7th Jul 20254:35 pmRNSPDMR / PCA Shareholding
4th Jul 202511:00 amRNSNotice of AGM and Publication of Annual Report
26th Jun 20257:00 amRNSPreliminary Group Results FY2025
2nd Jun 20257:00 amRNSNotice of Results and Investor Presentation
16th Apr 20252:00 pmRNSDirector/PDMR Shareholding
16th Apr 20251:00 pmRNSDirector/PDMR Shareholding
10th Apr 20256:00 pmRNSDirector/PDMR Shareholding
7th Apr 20257:00 amRNSFull Year Trading Update
19th Mar 20253:30 pmRNSDirector/PDMR Shareholding
13th Mar 20255:45 pmRNSHolding(s) in Company
27th Jan 20257:00 amRNSChange of Adviser
27th Jan 20257:00 amRNSTrading Update
16th Jan 20251:15 pmRNSDirector/PDMR Shareholding
16th Jan 20251:15 pmRNSDirector/PDMR Shareholding
3rd Jan 20257:00 amRNSDeferred Consideration for Acquisition
19th Dec 20247:00 amRNSForm 8.3 - Volex PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.